Skip to main content
Clinical Trials/NCT04791995
NCT04791995
Completed
Not Applicable

REsuscitation and CAPillary rePerfusion - A Cohort Study With Prospective Inclusion

Medical University of Vienna1 site in 1 country50 target enrollmentMarch 3, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiac Arrest
Sponsor
Medical University of Vienna
Enrollment
50
Locations
1
Primary Endpoint
Capillary refill time (CRT)
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Persistent microperfusion alterations after return of spontaneous circulation (ROSC) are associated with poor survival. To our knowledge, no human studies evaluating microperfusion during cardiopulmonary resuscitation (CPR) with simple and pre-hospital available tests have been published. Capillary refill time (CRT) and skin-mottling-score (SMS) are parameters for microperfusion and evaluated in septic and cardiogenic shock. In animal studies, microperfusion was impaired during cardiac arrest, although not correlating with systemic blood pressure.

The aim of this study is to investigate the correlation between impaired microcirculation (as measured with CRT and SMS) during resuscitation and ROSC resp. neurological outcome. Our clinical impression in daily routine is, that the appearance of a patient undergoing CPR is often linked to the outcome. We hypothesize, that this is due to changes in microperfusion of the skin.

Registry
clinicaltrials.gov
Start Date
March 3, 2021
End Date
May 1, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Michael Holzer

Prof. Michael Holzer

Medical University of Vienna

Eligibility Criteria

Inclusion Criteria

  • All patients ≥18 years during cardiopulmonary resuscitation
  • witnessed cardiac arrest

Exclusion Criteria

  • insufficient manpower (e.g. study team has to provide CPR)
  • hypovolemia (exsanguination, anaphylaxis, sepsis as underlying cause)
  • presumed or known COVID-19 disease
  • hypo-/hyperthermia (\<36.0°, \>37.5°C)
  • Raynaud's disease
  • Peripheral arterial disease

Outcomes

Primary Outcomes

Capillary refill time (CRT)

Time Frame: baseline (immediately after inclusion to the study)

Capillary refill time in seconds measured on one finger and one earlobe for ROSC vs. no ROSC

Secondary Outcomes

  • Skin mottling score (SMS)(baseline (immediately after inclusion to the study = minute 0), minute 2, 4, 6, 8, (...) up to return of spontaneous circulation or death, whichever came first)
  • Correlation of catecholamine demand during the first 48 hours after ROSC and CRT/SMS(from ROSC up to 48 hours after ROSC)
  • Correlation of CRT/SMS and lactate(baseline (immediately after inclusion to the study))
  • Capillary refill time (CRT)(minute 2, 4, 6, 8, (...) up to return of spontaneous circulation or death, whichever came first)
  • Capillary blood lactate (Lac)(baseline (immediately after inclusion to the study, = minute 0), minute 4, 8, 12, 16, 20)
  • Hospital mortality(baseline (immediately after inclusion to the study))
  • Correlation of CRT, SMS and Lac and 30 days good neurological outcome(baseline (immediately after inclusion to the study))
  • Correlation of CRT, SMS and Lac and hospital discharge good neurological outcome(baseline (immediately after inclusion to the study))
  • Correlation of SMS and CRT(baseline (immediately after inclusion to the study))
  • Correlation of time since cardiac arrest and CRT/SMS/lactate(baseline (immediately after inclusion to the study))

Study Sites (1)

Loading locations...

Similar Trials